| Literature DB >> 25211502 |
Catalina A Denman1, Cecilia Rosales2, Elsa Cornejo3, Melanie L Bell2, Diana Munguía3, Tanyha Zepeda2, Scott Carvajal2, Jill Guernsey de Zapien2.
Abstract
INTRODUCTION: Meta Salud is a community health worker-facilitated intervention in Hermosillo, Sonora, Mexico, and was adapted from Pasos Adelante, a similar evidence-based intervention developed for a Latino population in the United States-Mexico border region. The objective of this study was to examine outcomes for Meta Salud and compare them with outcomes for Pasos Adelante.Entities:
Mesh:
Year: 2014 PMID: 25211502 PMCID: PMC4164035 DOI: 10.5888/pcd11.140218
Source DB: PubMed Journal: Prev Chronic Dis ISSN: 1545-1151 Impact factor: 2.830
Figure 1Flow diagram of participants in the evaluation study for Meta Salud, a 13-week community-based program for the primary prevention of chronic disease conducted in Hermosillo, Sonora, Mexico, 2011–2012.
Sociodemographic and Health Characteristics of Meta Salud Participants and Comparisons of Participants Who Completed All Assessments With Those Who Missed ≥1 Assessment, Hermosillo, Sonora, Mexico, 2011–2012a
| Characteristic | Baseline Participants (n = 171) | Participants Who Completed All Assessments (n = 85) | Participants Who Missed ≥1 Assessment (n = 86) |
|
|---|---|---|---|---|
|
| ||||
|
| 41.5 (10.6) | 42.7 (10.9) | 40.3 (10.3) | .15 |
|
| 168 (98) | 85 (100) | 83 (98) | — |
|
| ||||
| Married | 147 (85) | 74 (87) | 73 (87) | .68 |
| Single/divorced/widowed | 24 (15) | 11 (13) | 13 (13) | .68 |
|
| ||||
| Some elementary | 27 (16) | 11 (13) | 16 (19) | .40 |
| Completed elementary | 26 (15) | 10 (12) | 16 (19) | .40 |
| Some high school | 100 (59) | 53 (62) | 47 (55) | .40 |
| Completed high school | 11 (6) | 6 (7) | 5 (7) | .40 |
| Post high school | 7 (4) | 5 (6) | 2 (6) | .40 |
|
| 62 (36) | 27 (32) | 35 (41) | .22 |
|
| 167 (98) | 84 (98) | 83 (98) | — |
|
| ||||
| <5 | 8 (5) | 4 (5) | 4 (5) | .52 |
| 6-10 | 14 (8) | 9 (11) | 5 (6) | .52 |
| >10 | 149 (87) | 72 (85) | 77 (90) | .52 |
|
| 126 (74) | 64 (75) | 62 (72) | .63 |
|
| ||||
|
| 105 (61) | 55 (65) | 50 (58) | .38 |
|
| 29 (17) | 14 (16) | 15 (17) | .87 |
|
| ||||
| <1 | 6 (221) | 4 (29) | 2 (13) | — |
| 1–5 | 7 (24) | 3 (21) | 4 (27) | — |
| 6–10 | 6 (21) | 2 (14) | 4 (27) | — |
| >10 | 7 (24) | 3 (21) | 4 (27) | — |
| Do not know | 3 (10) | 2 (14) | 1 (7) | — |
|
| ||||
| >25.0 | 24 (24) | 13 (16) | 11 (12) | .07 |
| 25.0–29.9 | 52 (30) | 31 (38) | 21 (23) | .07 |
| 30.0–39.9 | 81 (47) | 31 (38) | 50 (54) | .07 |
| >40 | 17 (10) | 6 (7) | 11 (12) | .07 |
|
| 12 (7) | 7 (8) | 5 (6) | .54 |
|
| 52 (30) | 22 (26) | 30 (35) | .20 |
|
| 38 (22.2) | 20 (24) | 18 (21) | .68 |
|
| 12 (7) | 5 (6) | 7 (8) | .56 |
|
| 27 (15.8) | 10 (12) | 17 (20) | .31 |
Abbreviation: SD, standard deviation.
All values are number (percentage) unless otherwise indicated.
Although 184 patients consented to participate, only 171 completed the baseline questionnaire.
χ2 tests not conducted because of small sample size.
Health Outcomes for Participants in Meta Salud at Baseline, Conclusion, and 3-Month Follow-up, Hermosillo, Sonora, Mexico, 2011–2012
| Outcome | Adjusted | Change (95% CI) | |||||
|---|---|---|---|---|---|---|---|
| Baseline (N = 177) | Conclusion (n = 176) | 3-Month Follow-up (n = 149) | Baseline Minus Conclusion |
| Baseline Minus 3-Month Follow-up |
| |
|
| |||||||
| Body mass index, kg/m2 | 31.3 (6.2) | 31.0 (6.4) | 31.0 (6.6) | 0.26 (0.10 to 0.42) | .001 | 0.26 (0.09 to 0.43) | .002 |
| Waist circumference, cm | 97.6 (13.4) | 96.7 (13.2) | 96.6 (13.5) | 0.91 (0.25 to 1.57) | .007 | 1.00 (0.30 to 1.69) | .005 |
| Hip circumference, cm | 109.7 (11.8) | 109.1 (11.9) | 109.5 (12.1) | 0.56 (0.02 to 1.09) | .04 | 0.21 (−0.5 to 0.78) | .46 |
| Waist-to-hip ratio | 0.89 (0.07) | 0.89 (0.07) | 0.88 (0.07) | 0.004 (−0.002 to 0.01) | .20 | 0.007 (0.001 to 0.01) | .02 |
| Weight, kg | 77.3 (15.6) | 76.7 (15.9) | 76.7 (15.8) | 0.63 (0.24 to 1.02) | .002 | 0.66 (0.24 to 1.11) | .002 |
|
| |||||||
| Total cholesterol | 190.9 (44.5) | 185.2 (35.3) | 177.7 (32.1) | 5.66 (−1.2 to 12.6) | .11 | 14.2 (6.6 to 21.8) | <.001 |
| HDL cholesterol (mg | 51.6 (16.6) | 51.7 (16.0) | 62.6 (17.0) | −0.15 (−2.9 to 2.6) | .91 | −11.1 (−14.1 to −8.1) | <.001 |
| LDL cholesterol | 109.5 (45.0) | 101.5 (33.6) | 87.8 (27.3) | 7.93 (1.02 to 14.84) | .02 | 21.6 (14.0 to 29.2) | <.001 |
| Triglycerides | 133.9 (80.3) | 160.3 (77.1) | 138.8 (67.4) | −26.4 (−40.4 to −12.4) | <.001 | −5.0 (−20.3 to 10.4) | 0.53 |
| Glucose | 114.5 (49.1) | 113.3 (45.9) | 106.9 (48.6) | 1.17 (−5.60 to 7.94) | .73 | 7.55 (0.08 to 15.0) | .05 |
Abbreviation: SD, standard deviation; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Means derived from the linear mixed model described in the Methods section.
Sample sizes are n = 129 at baseline, n = 118 at conclusion, and n = 91 at 3-month follow-up.
Figure 2Comparison of outcomes from 2 chronic disease prevention programs: Meta Salud (Northern Mexico, 2011–2012) and Pasos Adelante (Southern Arizona, 2005–2008). Values are standardized effect sizes of the difference from baseline to conclusion and 95% confidence intervals.
| Outcome | Study | Effect Size (95% Confidence Interval) |
|---|---|---|
| Body mass index | Pasos Adelante | 0.14 (0.01 to 0.27 ) |
| Meta Salud | 0.24 (0.09 to 0.39) | |
| Waist circumference | Pasos Adelante | 0.73 (0.58 to 0.88) |
| Meta Salud | 0.20 (0.05 to 0.35) | |
| Hip circumference | Pasos Adelante | 0.64 (0.50 to 0.79) |
| Meta Salud | 0.15 (0.01 to 0.30) | |
| Waist-to-hip ratio | Pasos Adelante | 0.22 (0.09 to 0.36) |
| Meta Salud | 0.10 (−0.05 to 0.24) | |
| Total cholesterol | Pasos Adelante | 0.18 (0.05 to 0.31) |
| Meta Salud | 0.14 (−0.03 to 0.32) | |
| Triglycerides | Pasos Adelante | −0.01 (−0.14 to 0.12) |
| Meta Salud | −0.33 (−0.50 to −0.15) | |
| High-density lipoprotein cholesterol | Pasos Adelante | 0.12(−0.01 to 0.26) |
| Meta Salud | −0.01 (−0.18 to 0.16) | |
| Low-density lipoprotein cholesterol | Pasos Adelante | 0.11(−0.02 to 0.25) |
| Meta Salud | 0.20 (0.02 to 0.37) | |
| Glucose | Pasos Adelante | −0.03(−0.16 to 0.10) |
| Meta Salud | 0.03 (−0.14 to 0.20) |